U.S. pharmaceutical concern Johnson & Johnson on
Tuesday reported a fall in third quarter net income to $3 billion, or $1.15 a share, down from $3.2 billion in the same
period last year.
The 7.3 percent decline was attributed to increased research and production costs.
Revenues rose to $17.1 billion, a rise of 6.5 percent over the same quarter last year. The stronger dollar hurt the value of foreign sales, which otherwise would have grown 10.8 percent over the same quarter last year, the company said.
Most Popular Stories
- SEO Traffic Lab Celebrate Wins at Digital Marketing Event 'Internet World 2013' in London
- Social Media Initiatives Should Follow Customers' Lead
- Apple CEO: Offshore Units Not a 'Tax Gimmick'
- U.S. Senate Accuses Apple of Large-scale Tax Avoidance
- UTEP Water Recycling Project Wins Venture Titles
- Marketo Makes a Mint in IPO: Stock Shoots Up More than 50 Percent
- Bieber Booed at Billboard Awards
- Crude Oil Up, Gasoline Down
- Austin Startup Compare Metrics Raises $3.5 Million for Expansion
- Why So Many Top 'Car Guys' Are Actually Women